Golden Lotus Ventures acquires, supplies, and operationally transforms independent metabolic health clinics across the United States. We build what clinic owners never had access to on their own.
The metabolic health market is fragmented, undervalued, and at an inflection point. Independent clinic owners are generating strong clinical outcomes with no exit path, no operational infrastructure, and significant revenue left on the table. GLV is built to change that.
We acquire established metabolic health clinics, med spas, and hormone therapy practices doing $500Kâ$5M in revenue and integrate them into a unified operational platform.
Our proprietary supply chain gives every clinic we work with access to advanced regenerative and therapeutic compounds, wound care, stem cell therapies, red light therapy, and lab-as-a-service solutions that unlock adjacent revenue.
We deploy proprietary AI systems across every acquired clinic: patient acquisition, billing optimization, retention, and operational efficiency. What independents couldn't afford to build alone.
Most acquirers see a revenue line. We see clinical mix, GLP-1 pipelines, adjacent service potential, and the exact gaps holding every practice back. That's a different lens entirely.
We evaluate peptide mix, GLP-1 pipelines, and adjacent service potential. We see value pure financial buyers miss.
Golden Lotus Labs feeds every acquired clinic. Margin captured on both sides of the transaction.
20+ years scaling businesses across biotech, Fortune 100 consulting, and health marketing. We've been inside these businesses.
We preserve what clinic owners built. This isn't a buyout. It's a partnership with real infrastructure behind it.
The practices that build infrastructure now will own their markets. The ones that wait will sell at lower multiples to buyers with less to offer.